Multi-modal Cardiac Application

About CytoTronics

Founded in 2019 and based in Cambridge, Massachusetts, CytoTronics is a private, platform-technology company focused on transforming cell biology discovery. Its core product, the Pixel™ system, integrates a semiconductor-to-live-cell interface with cloud-based analytics to provide unprecedented, data-rich insights into live cell function at scale. The company appears to be in an early-revenue stage, leveraging its technology to enable applications in neurological, cardiovascular, and oncology research, and has recently executed a strategic asset sale of a specific MEA technology to Axion BioSystems.

Therapeutic Areas